One FTSE 250 dividend stock I’d sell to buy this surging growth star

This FTSE 250 (INDEXFTSE: MCX) stock looks to be struggling and there’s at least one better buy out there.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Everyman Media (LSE: EMAN) claims that it is “redefining cinema” by offering customers a more bespoke and comfortable experience than that provided by peers such as Cineworld (LSE: CINE). 

The strategy seems to be working. Today the company reported that for the 52 weeks to the end of December, revenue grew 37% to £40.6m, and cinema admissions expanded 32% to 2.2m. 

It appears the bulk of this growth was at existing premises. Specifically, today’s release notes that just two Everyman venues opened during 2017, expanding the portfolio by 10% to 22 sites. The company also undertook some significant renovations of its existing portfolio throughout the year, including adding to new screens to its Muswell Hill and Oxted venues.

A premium offering

Everyman’s strength is its premium offering, which consumers are more than happy to pay for according to the firm’s figures. Last year the company recorded an average box office ticket price of £11.28, and average food and beverage spend per head of £5.97. These figures are more than double those reported by Cineworld. For the period to the end of June 2017, Cineworld achieved an average ticket price per head of £5.27 and an average retail spend per person of £2.04.

That said, nine of Everyman’s 22 screens, or 40% of the current portfolio, are based in London where prices are higher than the rest of the UK, but so are operating costs. Still, Everyman is more profitable than Cineworld overall with a gross profit margin of 60% compared to Cineworld’s 26%.

And when it comes to growth, the young upstart has an edge over its older, more established peer.

Set for growth

Everyman exchanged contracts on nine news sites during 2017 funded through an equity raise of £17m in October. Another deal was completed in January of 2018 when the firm exchange contracts on a freehold site in Crystal Palace, London for £3.3m. (With only £7m of debt on the balance sheet at year-end, and a net cash balance of £11.4m, I wouldn’t rule out more of these deals in 2018.) 

As these new venues begin to open, City analysts believe net profit could grow by as much as 40% in 2018 and earnings per share could hit 4.9p. Based on these numbers the shares are trading at a forward P/E ratio of 39.4, which looks expensive, but when you consider the company’s cash-rich balance sheet and rapid growth rate, it is clear the business deserves a high multiple.

Meanwhile, following the acquisition of US cinema group Regal, (completed in February) City analysts are expecting Cineworld’s revenue to jump 225% in 2018, and net profit is expected to double. However, because the company relied on a rights issue to finance part of the deal, earnings per share are only expected to grow by 22% thanks to the dilution.

Further, the group is drowning in debt following the merger, with analysts estimating that net debt to earnings before interest, taxes, depreciation and amortisation will be 4 times this year, leaving management little room for manoeuvre if things don’t go to plan.

Considering all of the above, even though shares in Cineworld look cheaper than Everman (the shares are trading at a forward P/E of 12 and support a dividend yield of 4.4%) I’d stay away from the group. Everyman appears to offer a better all-round proposition for investors. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »